Sanara MedTech Inc. - Common Stock (SMTI)
Healthcare › Medical Instruments & Supplies
Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- P/B of 28.21 — trading above book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -505.0%
- Revenue growing at 19% annually
Sanara MedTech Inc. - Common Stock (SMTI) is a Healthcare company operating in Medical Instruments & Supplies, listed on the NASDAQ , with a market capitalisation of $198 million . Key value metrics: P/B ratio 28.21, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Sanara MedTech Inc. - Common Stock — Fundamental Analysis Summary
On financial health, SMTI shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -505.0% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 7.00.
StockPik's composite Value Score for SMTI is 39/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SMTI reports a high gross margin of 92.7% (sector average: 40.1%) and a modest operating margin of 3.4%.
SMTI shows revenue growing at 19% year-over-year, with earnings declining at 289%.